Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study.
Dhingra
K
K
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Fritsche
H
H
Murray
J L
JL
LoBuglio
A F
AF
Khazaeli
M B
MB
Kelley
S
S
Tepper
M
M
Greene
D
D
Booser
D
D
Buzdar
A
A
D000328:Adult; D000368:Aged; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis*; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000917:Antibody Formation / Q000187:drug effects; D005260:Female; D006146:Guanidines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D013045:Species Specificity
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D006146:Guanidines; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; C037258:gusperimus